E1	Age:T1 Numeric-Filter:E2
E2	Eq-Comparison:T2 Value:T80 Operator:T81 Value:T82 Temporal-Unit:T83
E3	Condition:T3 Name:T84
E4	Observation:T4 Name:T133
E5	Age:T5 Numeric-Filter:E6
E6	Eq-Comparison:T6 Operator:T85 Value:T86 Temporal-Unit:T87
E7	Age:T7 Numeric-Filter:E8
E8	Eq-Comparison:T8 Operator:T88 Value:T89 Temporal-Unit:T90
E9	Modifier:T9 Modifies:T91
E10	Condition:T10 Name:T91
E11	Condition:T11 Name:T92
E12	Allergy:T12 Name:T134
E13	Other:T13 Is-Other:E14
E14	Condition:T14 Name:T93
E15	Modifier:T15 Modifies:E16
E16	Condition:T16 Acuteness:T74
E17	Condition:T17 Name:T95
E18	Eq-Comparison:T18 Temporal-Period:T96
E19	Condition:T19 Name:T97 Temporality:E18
E20	Condition:T20 Name:T98
E21	Condition:T21 Name:T99
E23	Condition:T23 Name:T100 Acuteness:T22
E24	Condition:T24 Name:T101
E25	Condition:T25 Name:T102
E26	Condition:T26 Name:T103
E27	Condition:T27 Name:T104
E29	Condition:T29 Name:T105 Acuteness:T28
E30	Condition:T30 Name:T106
E31	Modifier:T31 Modifies:T106
E34	Drug:T34 Name:T108
E36	Modifier:T36 Modifies:T109
E38	Modifier:T38 Modifies:T109
E39	Drug:T39 Name:T109
E41	Eq-Comparison:T41 Value:T110 Temporal-Unit:T111
E43	Study:T43 
E44	Procedure:T44 Temporality:E49
E45	Drug:T45 Name:T112
E46	Drug:T46 Name:T113
E48	Drug:T48 Name:T114
E49	Eq-Comparison:T49 Value:T115 Temporal-Unit:T116
E51	Study:T51 
E52	Drug:T52 Name:T118 Temporality:E58
E55	Drug:T55 Name:T119 Temporality:E58
E57	Procedure:T57 Name:T120 Temporality:E58
E58	Eq-Comparison:T58 Temporal-Period:T121 Value:T122 Temporal-Unit:T123
E59	Drug:T59 Name:T125
E61	Drug:T61 
E63	Eq-Comparison:T63 Value:T127 Temporal-Unit:T128
E65	Study:T65 
E66	Other:T66 Is-Other:E67
E67	Study:T67 Study-Of:E70
E68	Study:T68 Study-Of:E70
E70	Drug:T70 Temporality:E72
E72	Eq-Comparison:T72 Operator:T129 Value:T130 Temporal-Unit:T131
E75	Study:T75 
E76	Condition:T76 Name:T132
E77	Study:T77 Study-Of:E78
E78	Drug:T78 
E33	Modifier:T33 Modifies:T106
E80	Drug:T135 Name:T136
E54	Modifier:T54 Modifies:T125
E81	Condition:T117 Name:T124
E82	Modifier:T126 Modifies:E70
E83	Modifier:T137 Modifies:E70
T1	Age 34 38	aged
T2	Eq-Comparison 39 50	6-36 months
T3	Condition 69 86	Atopic Dermatitis
T4	Observation 100 112	SCORAD index
T5	Age 137 140	Age
T6	Eq-Comparison 141 151	< 6 months
T7	Age 157 160	age
T8	Eq-Comparison 161 172	> 36 months
T9	Modifier 179 183	skin
T10	Condition 184 194	infections
T11	Condition 201 211	ichthyosis
T12	Allergy 223 232	allergies
T13	Other 239 244	other
T14	Condition 245 262	allergic diseases
T15	Modifier 277 285	systemic
T16	Condition 286 294	diseases
T17	Condition 301 327	congenital cardiac defects
T18	Eq-Comparison 334 340	active
T19	Condition 341 353	tuberculosis
T20	Condition 360 379	autoimmune diseases
T21	Condition 386 402	immunodeficiency
T22	Acuteness 409 416	chronic
T23	Condition 417 444	inflammatory bowel diseases
T24	Condition 451 465	celiac disease
T25	Condition 472 487	cystic fibrosis
T26	Condition 494 512	metabolic diseases
T27	Condition 519 529	malignancy
T28	Acuteness 536 543	chronic
T29	Condition 544 562	pulmonary diseases
T30	Condition 569 582	malformations
T31	Modifier 590 606	gastrointestinal
T34	Drug 656 666	prebiotics
T36	Modifier 679 688	symbiotic
T38	Modifier 689 697	systemic
T39	Drug 698 714	immunomodulators
T41	Eq-Comparison 726 733	4 weeks
T43	Study 741 750	enrolment
T44	Procedure 757 767	treatments
T45	Drug 773 797	topical immunomodulators
T46	Drug 799 809	Tacrolimus
T48	Drug 813 825	Pimecrolimus
T49	Eq-Comparison 827 848	over the three months
T51	Study 858 867	enrolment
T52	Drug 881 896	corticosteroids
T55	Drug 900 923	calcineurin antagonists
T57	Procedure 927 939	phototherapy
T58	Eq-Comparison 947 963	previous 4 weeks
T59	Drug 986 997	antibiotics
T61	Drug 1014 1019	drugs
T63	Eq-Comparison 1027 1034	4 weeks
T65	Study 1042 1047	study
T66	Other 1203 1208	other
T67	Study 1209 1216	studies
T68	Study 1227 1242	investigational
T70	Drug 1255 1263	products
T72	Eq-Comparison 1281 1297	within two weeks
T75	Study 1322 1327	study
T76	Condition 1334 1350	hypersensitivity
T77	Study 1378 1383	study
T78	Drug 1384 1391	product
T79	Life-Stage-And-Gender 25 33	Children
T80	Eq-Value 39 40	6
T81	Eq-Operator 40 41	-
T82	Eq-Value 41 43	36
T83	Eq-Temporal-Unit 44 50	months
T84	Condition-Name 69 86	Atopic Dermatitis
T85	Eq-Operator 141 142	<
T86	Eq-Value 143 144	6
T87	Eq-Temporal-Unit 145 151	months
T88	Eq-Operator 161 162	>
T89	Eq-Value 163 165	36
T90	Eq-Temporal-Unit 166 172	months
T91	Condition-Name 184 194	infections
T92	Condition-Name 201 211	ichthyosis
T93	Condition-Name 245 262	allergic diseases
T95	Condition-Name 301 327	congenital cardiac defects
T96	Eq-Temporal-Period 334 340	active
T97	Condition-Name 341 353	tuberculosis
T98	Condition-Name 360 379	autoimmune diseases
T99	Condition-Name 386 402	immunodeficiency
T100	Condition-Name 417 444	inflammatory bowel diseases
T101	Condition-Name 451 465	celiac disease
T102	Condition-Name 472 487	cystic fibrosis
T103	Condition-Name 494 512	metabolic diseases
T104	Condition-Name 519 529	malignancy
T105	Condition-Name 544 562	pulmonary diseases
T106	Condition-Name 569 582	malformations
T108	Drug-Name 656 666	prebiotics
T109	Drug-Name 698 714	immunomodulators
T110	Eq-Value 726 727	4
T111	Eq-Temporal-Unit 728 733	weeks
T112	Drug-Name 773 797	topical immunomodulators
T113	Drug-Name 799 809	Tacrolimus
T114	Drug-Name 813 825	Pimecrolimus
T115	Eq-Value 836 841	three
T116	Eq-Temporal-Unit 842 848	months
T118	Drug-Name 881 896	corticosteroids
T119	Drug-Name 900 923	calcineurin antagonists
T120	Procedure-Name 927 939	phototherapy
T121	Eq-Temporal-Period 947 955	previous
T122	Eq-Value 956 957	4
T123	Eq-Temporal-Unit 958 963	weeks
T125	Drug-Name 986 997	antibiotics
T127	Eq-Value 1027 1028	4
T128	Eq-Temporal-Unit 1029 1034	weeks
T129	Eq-Operator 1281 1287	within
T130	Eq-Value 1288 1291	two
T131	Eq-Temporal-Unit 1292 1297	weeks
T132	Condition-Name 1334 1350	hypersensitivity
T133	Observation-Name 100 112	SCORAD index
T134	Allergy-Name 218 222	food
T33	Modifier 614 631	respiratory tract
T135	Drug 668 678	probiotics
T136	Drug-Name 668 678	probiotics
T54	Modifier 977 985	systemic
T117	Condition 1006 1013	mycotic
T124	Condition-Name 1006 1013	mycotic
T126	Modifier 1246 1254	marketed
T137	Modifier 1264 1277	concomitantly
T74	Acuteness 269 276	chronic
A7	Life-Stage-And-Gender-Type T79 child
A8	Eq-Operator-Value T81 BETWEEN
A9	Eq-Temporal-Unit-Value T83 month
A10	Eq-Operator-Value T85 LT
A11	Eq-Temporal-Unit-Value T87 month
A12	Eq-Operator-Value T88 GT
A13	Eq-Temporal-Unit-Value T90 month
A14	Eq-Temporal-Period-Value T96 present
A15	Eq-Temporal-Unit-Value T111 week
A16	Eq-Temporal-Unit-Value T116 month
A18	Eq-Temporal-Period-Value T121 past
A19	Eq-Temporal-Unit-Value T123 week
A21	Eq-Temporal-Unit-Value T128 week
A22	Eq-Operator-Value T129 LTEQ
A23	Eq-Temporal-Unit-Value T131 week
A24	Observation-Type-Value E4 clinical-score
A25	Acuteness-Type-Value T22 chronic
A26	Acuteness-Type-Value T28 chronic
A27	Acuteness-Type-Value T74 chronic
R1	Found-By Arg1:E3 Arg2:E4
R2	Using Arg1:E44 Arg2:E45
R3	Example-Of Arg1:E46 Arg2:E45
R4	Example-Of Arg1:E48 Arg2:E45
R5	Treatment-For Arg1:E61 Arg2:E81
R6	Caused-By Arg1:E76 Arg2:E78
R7	Or Arg1:E31 Arg2:E33
R8	Or Arg1:E80 Arg2:E39
R9	Or Arg1:E36 Arg2:E38
R10	During Arg1:E39 Arg2:E41
R11	Before Arg1:E41 Arg2:E43
R12	Or Arg1:E46 Arg2:E48
R13	Before Arg1:E49 Arg2:E51
R14	Or Arg1:E52 Arg2:E55
R15	Or Arg1:E55 Arg2:E57
R16	Or Arg1:E59 Arg2:E61
R17	During Arg1:E61 Arg2:E63
R18	Before Arg1:E63 Arg2:E65
R19	Or Arg1:E68 Arg2:E82
R20	Or Arg1:E83 Arg2:E72
R21	Before Arg1:E72 Arg2:E75
R22	Or Arg1:E34 Arg2:E80
